S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Home
Investing
Stocks
USA
NASDAQ
Cytek Biosciences Inc (CTKB)
Cytek Biosciences Inc (CTKB) News

Cytek Biosciences Inc (CTKB)

4.055

0.195

( 5.05% )

Updated: 09:28:34

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference

FREMONT, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell...

Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK, June 5...

Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026

FREMONT, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- At CYTO 2026, the industry’s premier flow cytometry...

Form 8-K - Current report

Form SD - Specialized disclosure report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech

VMS+™ 4.0 system collects a 2026 Edison Award Gold Medal, advances to NMPA regulatory submission in China, and...

1
Next

boston127

boston127 3 minutes ago

You can buy ADTX on Schwab.

That is where I have my shares also.

electric1

electric1 3 minutes ago

The increased volume is from insiders cashing in on gifted shares period. This Ged guy was hired to solicit reputable law firms and nothing more. We have been disappointed so many times with "it's so exciting" and "something is happening" it makes me sick. The only ones making money here are Emil

I am done

I am done 4 minutes ago

$IGC IGC Pharma's AHA Agentic AI Platform Reduces Alzheimer's Data Harmonization Time by 90% in Representative Workflow
https://www.accessnewswire.com/newsroom/en/biotechnology/igc-pharmas-aha-agentic-ai-platform-reduces-alzheimers-data-harmonization-time-by-90-1180813

cashclan

cashclan 4 minutes ago

Seems to me...

1 Unit @ $3,000,000 would have solved the reflection pool problem that they spent what 12 million on ...

MG...should be making some calls ...imho

tapioca

tapioca 4 minutes ago

Canouse taught Mederos well, on how to rape the blind sheep..

cancerfreed

cancerfreed 5 minutes ago

Be careful. You can be one of many bag holders for awhile. You cannot compete against hedgefunds

I am done

I am done 5 minutes ago

$IGC IGC Pharma's AHA Agentic AI Platform Reduces Alzheimer's Data Harmonization Time by 90% in Representative Workflow
https://www.accessnewswire.com/newsroom/en/biotechnology/igc-pharmas-aha-agentic-ai-platform-reduces-alzheimers-data-harmonization-time-by-90-1180813

Huggy Bear

Huggy Bear 5 minutes ago

What company 😂 ???

This isn't a company, it's a total fraud

The Truth Hurts

The Truth Hurts 5 minutes ago

Of course. No clarity and no updates. Not suprised peeps are selling.

Truenorth2016

Truenorth2016 5 minutes ago

That sound like a Defense Contract Resume, as if this is something they are using as leverage to seal further nearterm contracts, its all about proving yourself and this sounds like this is what they are bringing to the table when negotiating contracts, sounds very strategiv and intentional.

Smartypants2

Smartypants2 6 minutes ago

Please show me where you were being obviously sarcastic. And I didn't say I know how they did it. I only asked if you ever considered that there might be alternatives to paying for the R&D work. For example, rather than paying for the R&D upfront, perhaps they offered some deferred form of compensat

DrHigh

DrHigh 6 minutes ago

if there is no approval, the presentation won't matter. they will at most send an email letting shareholders know about the presentation. retail is for the most part tapped out. If we get approval then the presentation wont matter from an investment standpoint either. Stock will hopefully rally base

MONTI KING

MONTI KING 6 minutes ago

Interesting X post :
$VGLS - we are closely monitoring this play, obviously structured now as a low float shell company. Depends what they vend in it will be very interesting . The majority holder shares will be restricted only only 1% per year of outstanding can be sold (legally) - very in

JP313

JP313 6 minutes ago

Getting worse here day by day here bud

Gold prospector

Gold prospector 6 minutes ago

Nothing, but we do know they spent a great deal of time and money cleaning up the shell. 70 million float extremely low! We could be looking at pennies easily in the future!

stevhoff

stevhoff 6 minutes ago

$AMC just announced a secondary offering of 95 million shares. They will have 890 million outstanding after the offering. They had 140 million out back in 2022. That's adjusted for the 10-1 reverse split they had in 2023. Meanwhile $CNK has reduced their outstanding share count from 120 million to 1

?? WALLSTREET SIGNAL ??

?? WALLSTREET SIGNAL ?? 7 minutes ago

Special Report | $DYAI Dyadic Inc. highlights increased interest in the C1 biomanufacturing platform amid Ebola preparedness and growing commercial adoption

Read more | https://finance.yahoo.com/sectors/healthcare/articles/dyadic-highlights-accelerated-interest-c1-112500620.html

cancerfreed

cancerfreed 7 minutes ago

People are loading up shares at lower price just to flip them later when it goes back up. This cycle will continue until who knows when it is going to stop

imanjen13

imanjen13 7 minutes ago

While there are around a billion of so outstanding shares, more than half are owned by insiders, leaving the float around 500M shares for public trading. The stock current daily trade volume is only 1% of the float.

?? WALLSTREET SIGNAL ??

?? WALLSTREET SIGNAL ?? 8 minutes ago

Special Report | $DYAI Dyadic Inc. highlights increased interest in the C1 biomanufacturing platform amid Ebola preparedness and growing commercial adoption

Read more | https://finance.yahoo.com/sectors/healthcare/articles/dyadic-highlights-accelerated-interest-c1-112500620.html

Don

Don 8 minutes ago

It’s not hard to be debt free when you dump 4 billion shares on your investors.

katiesdad7

katiesdad7 9 minutes ago

Time to buy back.

Porch Honkey

Porch Honkey 9 minutes ago

$AEFI,
Hey big whale flipper, how about giving us little fish a break here, thanks in advance, lol.

Cytek Biosciences

Societe Generale Effekten

Global X Adaptive Us Ris...

Harvard Ave Acquisition

UBS CMCI exAgriculture S...

Medexus Pharmaceuticals

VanEck World Equal Weigh...

Municipality Finance Plc...

Autoscope Technologies (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN

Already have an account? Sign in

Don't have an account? Sign up

By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.